Michael Robich1, Sergey Ryzhov2, Doreen Kacer2, Monica Palmeri1, Sarah M Peterson2, Reed D Quinn3, Damien Carter4, Forest Sheppard5, Timothy Hayes6, Douglas B Sawyer1, Joseph Rappold7, Igor Prudovsky2, Robert S Kramer8. 1. Maine Medical Center Cardiovascular Institute, Portland, Maine; Maine Medical Center Research Institute, Scarborough, Maine. 2. Maine Medical Center Research Institute, Scarborough, Maine. 3. Maine Medical Center Cardiovascular Institute, Portland, Maine. 4. Maine Medical Center Research Institute, Scarborough, Maine; Maine Medical Center, Department of Surgery, Portland, Maine. 5. Maine Medical Center, Department of Surgery, Portland, Maine. 6. Maine Medical Center, Department of Pathology, Portland, Maine. 7. Maine Medical Center Cardiovascular Institute, Portland, Maine; Maine Medical Center Research Institute, Scarborough, Maine; Maine Medical Center, Department of Surgery, Portland, Maine. 8. Maine Medical Center Cardiovascular Institute, Portland, Maine; Maine Medical Center Research Institute, Scarborough, Maine. Electronic address: kramer@mmc.org.
Abstract
BACKGROUND: The endothelial glycocalyx (EG) is involved in critical regulatory mechanisms that maintain endothelial vascular integrity. We hypothesized that prolonged cardiopulmonary bypass (CPB) may be associated with EG degradation. We performed an analysis of soluble syndecan-1 levels in relation to duration of CPB, as well as factors associated with cell stress and damage, such as mitochondrial DNA (mtDNA) and inflammation. METHODS: Blood samples from subjects undergoing cardiac surgery with CPB (n = 54) were obtained before and during surgery, 4-8 h and 24 h after completion of CPB, and on postoperative day 4. Flow cytometry was used to determine subpopulations of white blood cells. Plasma levels of mtDNA were determined using quantitative polymerase chain reaction and plasma content of shed syndecan-1 was measured. To determine whether syndecan-1 was signaling white blood cells, the effect of recombinant syndecan-1 on mobilization of neutrophils from bone marrow was tested in mice. RESULTS: CPB is associated with increased mtDNA during surgery, increased syndecan-1 blood levels at 4-8 h, and increased white blood cell count at 4-8 h and 24 h. Correlation analysis revealed significant positive associations between time on CPB and syndecan-1 (rs = 0.488, P < 0.001) and level of syndecan-1 and neutrophil count (rs = 0.351, P = 0.038) at 4-8 h. Intravenous administration of recombinant syndecan-1 in mice resulted in a 2.5-fold increase in the number of circulating neutrophils, concurrent with decreased bone marrow neutrophil number. CONCLUSIONS: Longer duration of CPB is associated with increased plasma levels of soluble syndecan-1, a signal for EG degradation, which can induce neutrophil egress from the bone marrow. Development of therapy targeting EG shedding may be beneficial in patients with prolonged CPB.
BACKGROUND: The endothelial glycocalyx (EG) is involved in critical regulatory mechanisms that maintain endothelial vascular integrity. We hypothesized that prolonged cardiopulmonary bypass (CPB) may be associated with EG degradation. We performed an analysis of soluble syndecan-1 levels in relation to duration of CPB, as well as factors associated with cell stress and damage, such as mitochondrial DNA (mtDNA) and inflammation. METHODS: Blood samples from subjects undergoing cardiac surgery with CPB (n = 54) were obtained before and during surgery, 4-8 h and 24 h after completion of CPB, and on postoperative day 4. Flow cytometry was used to determine subpopulations of white blood cells. Plasma levels of mtDNA were determined using quantitative polymerase chain reaction and plasma content of shed syndecan-1 was measured. To determine whether syndecan-1 was signaling white blood cells, the effect of recombinant syndecan-1 on mobilization of neutrophils from bone marrow was tested in mice. RESULTS: CPB is associated with increased mtDNA during surgery, increased syndecan-1 blood levels at 4-8 h, and increased white blood cell count at 4-8 h and 24 h. Correlation analysis revealed significant positive associations between time on CPB and syndecan-1 (rs = 0.488, P < 0.001) and level of syndecan-1 and neutrophil count (rs = 0.351, P = 0.038) at 4-8 h. Intravenous administration of recombinant syndecan-1 in mice resulted in a 2.5-fold increase in the number of circulating neutrophils, concurrent with decreased bone marrow neutrophil number. CONCLUSIONS: Longer duration of CPB is associated with increased plasma levels of soluble syndecan-1, a signal for EG degradation, which can induce neutrophil egress from the bone marrow. Development of therapy targeting EG shedding may be beneficial in patients with prolonged CPB.
Authors: A E Kossakowska; D R Edwards; C Prusinkiewicz; M C Zhang; D Guo; S J Urbanski; T Grogan; L A Marquez; A Janowska-Wieczorek Journal: Blood Date: 1999-09-15 Impact factor: 22.113
Authors: Dirk Bruegger; Florian Brettner; Isabel Rossberg; Claudia Nussbaum; Christian Kowalski; Katarzyna Januszewska; Bernhard F Becker; Daniel Chappell Journal: Ann Thorac Surg Date: 2015-01-17 Impact factor: 4.330
Authors: Sean E Gill; Samuel T Nadler; Qinglang Li; Charles W Frevert; Pyong Woo Park; Peter Chen; William C Parks Journal: Am J Respir Cell Mol Biol Date: 2016-08 Impact factor: 6.914
Authors: Floor A Harms; Rinse Ubbink; Calvin J de Wijs; Max P Ligtenberg; Maarten Ter Horst; Egbert G Mik Journal: Front Med (Lausanne) Date: 2022-07-18
Authors: Akos Tiboldi; Johannes Führer; Wolfgang Schaubmayr; Eva Hunyadi-Gulyas; Marie Louise Zach; Beatrix Hochreiter; Andreas Spittler; Roman Ullrich; Klaus Markstaller; Friedrich Altmann; Klaus Ulrich Klein; Verena Tretter Journal: Antioxidants (Basel) Date: 2021-12-04